kirazmattson
290 posts
Jan 15, 2026
9:32 PM
|
Vilitra is an ED medication containing vardenafil, which is a PDE5 inhibitor like sildenafil (Fildena/Cenforce) and tadalafil (Vidalista). PDE5 inhibitors can affect the eyes in certain conditions, so caution is important. Here’s a detailed look: Eye Conditions That Can Interact with Vilitra Non-arteritic anterior ischemic optic neuropathy (NAION) NAION is a condition where blood flow to the optic nerve is reduced, causing sudden vision loss. PDE5 inhibitors like vardenafil have been associated with rare cases of NAION. Patients with a history of NAION in one eye are at Vilitra risk. Retinitis pigmentosa This is a rare genetic eye disorder affecting the retina. Some PDE5 inhibitors may worsen retinal problems, although data is limited. Use caution if you have a family history of retinal degeneration. Severe vision problems or eye injuries Sudden decrease in vision after taking vardenafil is a medical emergency. Symptoms like blurred vision, loss of color vision, or sudden visual field loss require immediate attention. Glaucoma (especially angle-closure glaucoma) PDE5 inhibitors can rarely increase intraocular pressure, which may worsen certain types of glaucoma. Caution is advised for those with unstable or severe glaucoma. Red Flag Symptoms to Watch For Sudden vision loss (partial or complete) Sudden decrease in visual acuity Distorted vision or flashes of light Eye pain with vision changes Key Takeaway: Patients with a history of NAION, retinitis pigmentosa, or certain types of glaucoma should use Vilitra only under strict medical supervision. Regular eye checkups are recommended if you take PDE5 inhibitors and have any pre-existing eye conditions.
|
